DBV Technologies S.A. (DBVT) — research page
US · us-cm-kg/NASDAQ/DBVT · as of 2026-11-08
Identity and listing
The issuer is DBV Technologies S.A., listed on NASDAQ under ticker DBVT, with ISIN US23306J3095. The LEI is not on the record, as there is no GLEIF record with the exact legal name in jurisdiction US-I0. The security type is Corporate, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is France. The segment is not on the record. The listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | DBV Technologies S.A. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | DBVT | source · 2026-11-08 |
| ISIN | US23306J3095 | source · 2026-10-14 |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2836 Biological Products, (No Diagnostic Substances) | source · 2026-11-08 |
| jurisdiction | France | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 54 filings across 39 filing days in the window 2025-11-08 to 2026-11-08. The filings comprise 24 regulatory filings, 10 directors' dealings, 9 results, 5 corporate news, 3 AGM/EGM, 2 director changes and 1 prospectus. The median gap between filing days is 6.0 days. The latest filing is a results filing dated 2026-10-28, which is 11 days before the record date of 2026-11-08. The exchange median gap is 6.0 days and the exchange median latency is 5.0 days, against a median of 52 filings across 4,359 NASDAQ issuers. The sector median gap is 5.5 days and the sector median latency is 4.0 days, against a median of 65.5 filings across 176 issuers. The issuer's 54 filings are below the sector median of 65.5 and above the exchange median of 52.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 54 | 6 | 11 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2836 Biological Products, (No Diagnostic Substances) (176 issuers) | 65.5 | 5.5 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-28 | results | 10-Q | 10-Q — 10-Q |
| 2026-10-28 | results | 8-K | 8-K — 8-K (items 2.02,9.01) |
| 2026-09-30 | corporate_news | 8-K | 8-K — 8-K (items 8.01,9.01) |
| 2026-08-14 | regulatory_filing | SCHEDULE 13G/A | SCHEDULE 13G/A |
| 2026-08-06 | regulatory_filing | SCHEDULE 13G | SCHEDULE 13G |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is Deloitte & Associés, located in Paris - La Défense. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting, name change, or segment move lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's own investor-relations page.
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001613780.json (identity.jurisdiction)
- 10.4
- https://mcp.us-cm-kg.ai/events/NASDAQ/DBVT (the disclosure lines)
- 10.5
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.6
- https://www.sec.gov/Archives/edgar/data/1613780/000162828026021504/dbvt-20251231.htm (the auditor)
- 10.7
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.8
- https://mcp.us-cm-kg.ai/record/NASDAQ/DBVT (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US23306J3095"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:20df2d48a8514184.